Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.
dc.contributor.author | Hunsicker, O | |
dc.contributor.author | Scott, MJ | |
dc.contributor.author | Miller, TE | |
dc.contributor.author | Baldini, G | |
dc.contributor.author | Feldheiser, A | |
dc.coverage.spatial | England | |
dc.date.accessioned | 2017-04-06T19:41:14Z | |
dc.date.available | 2017-04-06T19:41:14Z | |
dc.date.issued | 2015-07 | |
dc.identifier | ||
dc.identifier | aev181 | |
dc.identifier.eissn | 1471-6771 | |
dc.identifier.uri | ||
dc.language | eng | |
dc.publisher | Elsevier BV | |
dc.relation.ispartof | Br J Anaesth | |
dc.relation.isversionof | 10.1093/bja/aev181 | |
dc.subject | Colloids | |
dc.subject | Colorectal Surgery | |
dc.subject | Female | |
dc.subject | Fluid Therapy | |
dc.subject | Humans | |
dc.subject | Hydroxyethyl Starch Derivatives | |
dc.subject | Isotonic Solutions | |
dc.subject | Male | |
dc.title | Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy. | |
dc.type | Journal article | |
duke.contributor.orcid | Miller, TE|0000-0001-8567-6680 | |
pubs.author-url | ||
pubs.begin-page | 128 | |
pubs.end-page | 129 | |
pubs.issue | 1 | |
pubs.organisational-group | Anesthesiology | |
pubs.organisational-group | Anesthesiology, General, Vascular, High Risk Transplant & Critical Care | |
pubs.organisational-group | Clinical Science Departments | |
pubs.organisational-group | Duke | |
pubs.organisational-group | School of Medicine | |
pubs.publication-status | Published | |
pubs.volume | 115 |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Hunsicker letter. GI morbitidy as a primary outcome measure. 2015.pdf
- Size:
- 57.49 KB
- Format:
- Adobe Portable Document Format